On October 2, 2024, the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (FDA), and U.S.
A three-judge panel on the 9th U.S. Circuit Court of Appeals ruled that the FDA can regulate two affiliated Southern California stem cell clinics and their treatments after a lower court had exempted ...
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...
The software turns coronary CT angiography images into 3D models that quantify and classify plaque morphology to improve predictions of heart attack and stroke risk.
The U.S. Drug Enforcement Administration (DEA) has issued a public safety alert regarding a troubling rise in illegal online ...
The U.S. Food and Drug Administration has approved Cologuard Plus, the new version of Exact Sciences’ stool test for colon ...
Hammond's Candies is issuing a recall on its Dark Chocolate Filled Mini Waffle Cones, as they may be contaminated with an ...
Zacks.com on MSN1h
Zevra Stock Surges Close to 70% in 3 Months: Here's WhyZevra Therapeutics, Inc. ZVRA obtained FDA approval for arimoclomol capsules for the treatment of Niemann-Pick disease type C ...
The FDA convinced the US Supreme Court to consider a case over whether an electronic cigarette manufacturer may seek review ...
The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...
BeiGene has officially launched its PD-1 cancer drug Tevimbra in the U.S. more than six months after receiving a much-delayed ...
The stool-based test is the next-generation version of Exact's existing Cologuard test for colorectal cancer screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback